European Cardiac Arrhythmia Society annual congress

The European Cardiac Arrhythmia Society (ECAS) will hold its annual congress in Marseilles, France, from 2 to 4 April.

The programme includes a panel discussion on the need for new antiarrhythmic drugs for atrial fibrillation, new concepts in antiarrhythmic drugs for atrial fibrillation, dronedarone: pharmacology and electrophysiology, and the results of trials.

Sessions will address subjects such as catheter ablation for cardiac arrhythmias, ablation of atrial tachycardias, techniques for risk stratification of patients, and interpretation of intracardiac recordings.For further information, please consult the following web address:
http://www.ecas-congress.org(opens in new window)